Atlas Trials

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Clinical trial NCT05520853 · UNKNOWN

Trial details

NCT number
NCT05520853
Sponsor
First People's Hospital of Hangzhou
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
Start date
2020-01-20
Primary completion
2024-12-31
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.